Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00005392-199904010-00449PMID 9927041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells.

  1998cited by this paper
• The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses

  1998cited by this paper
• Efficient transfer of genes into senescent cells by adenovirus vectors via highly expressed alpha v beta 5 integrin.

  1997cited by this paper
• Efficient Transfer of Genes into Senescent Cells by Adenovirus Vectors via Highly Expressed αvβ5 Integrin

  1997cited by this paper
• HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

  1997cited by this paper
• Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

  1997influential reference
• A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor

  1996cited by this paper
• Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.

  1996cited by this paper
• Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

  1995cited by this paper
• Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.

  1995cited by this paper
• Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches.

  1995cited by this paper
• Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2

  1994cited by this paper
• Manipulation of adenovirus vectors.

  1991cited by this paper
• Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.

  1990cited by this paper
• Human adenovirus-host cell interactions: comparative study with members of subgroups B and C

  1990cited by this paper
• A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses

  1988cited by this paper
• DNA Preparation from Cultured Cells and Tissue

  1986cited by this paper
• An adenovirus type 5 early gene function regulates expression of other early viral genes.

  1979cited by this paper
• Unrelated animal viruses share receptors

  1976cited by this paper

• Intravesical interferon-α2b gene therapy with nadofaragene firadenovec-vncg: a contemporary review.

  2025cites this paper
• A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects.

  2024cites this paper
• Cell-targeting Nanomedicine for Bladder Cancer: A Cellular Bioengineering Approach for Precise Drug Delivery

  2024cites this paper
• Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy

  2024cites this paper
• The current status of gene therapy in bladder cancer

  2023cites this paper
• Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients

  2023cites this paper
• Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval

  2023cites this paper
• Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment

  2022influential citation
• Polymeric Systems for Cancer Immunotherapy: A Review

  2022cites this paper
• Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer

  2022cites this paper
• Species D Adenoviruses as Oncolytic Viral Vectors Species D Adenoviruses as Oncolytic Viral Vectors

  2021cites this paper
• JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy

  2021cites this paper
• Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and Meta-Analysis

  2020cites this paper
• Species D Adenoviruses as Oncolytic Viral Vectors

  2020cites this paper
• Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor

  2020cites this paper
• Spectrum-Wide Exploration of Human Adenoviruses for Breast Cancer Therapy

  2020cites this paper
• State‐of‐the‐art human adenovirus vectorology for therapeutic approaches

  2019cites this paper
• Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer

  2019cites this paper
• Viral Vectors for Gene Therapy

  2019cites this paper
• Current Use of Adenovirus Vectors and Their Production Methods.

  2019cites this paper
• Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens

  2018cites this paper
• Uusi-Kerttula, H. et al. (2018) Ad5NULL-A20: a tropism-modified, αvβ6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer

  2018cites this paper
• Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies

  2018cites this paper
• Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer

  2017cites this paper
• Development of ovarian cancer-targeted adenoviral vectors

  2017cites this paper
• Adaptation of vectors and drug‐inducible systems for controlled expression of transgenes in the tumor microenvironment

  2017cites this paper
• Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents

  2017cites this paper
• ERK1/2 pathway regulates coxsackie and adenovirus receptor expression in mouse cardiac stem cells

  2017cites this paper
• Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo

  2016cites this paper
• Potential for evolution of complex defense strategies in a multi-scale model of virus-host coevolution

  2016cites this paper
• Recent advances in oncolytic adenovirus therapies for cancer.

  2016cites this paper
• Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells.

  2016cites this paper
• KLF5 promotes cell migration by up‐regulating FYN in bladder cancer cells

  2016cites this paper
• The role of the Coxsackie and Adenoviral Receptor in TNF alpha driven inflammation

  2016cites this paper
• Nonmuscle invasive bladder cancer: a primer on immunotherapy

  2016cites this paper
• Adenovirus-host interactions : implications for tropism and therapy

  2016cites this paper
• Targeting of viral vectors for cancer gene therapy

  2016cites this paper
• HAdV-2-suppressed growth of SV40 T antigen-transformed mouse mammary epithelial cell-induced tumours in SCID mice.

  2016cites this paper
• Loss of CAR promotes migration and proliferation of HaCaT cells, and accelerates wound healing in rats via Src-p38 MAPK pathway

  2016cites this paper
• Improved Antitumor Effect of Survivin Responsive Conditional ReplicationAdenovirus in Combination with Cisplatin in Lung Cancer

  2016cites this paper
• Coxsackievirus and Adenovirus Receptor, a Tight Junction Protein, in Peri-Implantation Mouse Embryos1

  2016cites this paper
• Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies

  2016cites this paper
• Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies

  2015cites this paper
• RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells

  2015cites this paper
• Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells

  2015cites this paper
• γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest

  2015cites this paper
• Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

  2015cites this paper
• Inhibition of GPR137 suppresses proliferation of medulloblastoma cells in vitro

  2015cites this paper
• Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications

  2015cites this paper
• The IgCAMs CAR, BT-IgSF, and CLMP: structure, function, and diseases.

  2014cites this paper
• Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer.

  2014cites this paper
• Recent advancements in optofluidics-based single-cell analysis: optical on-chip cellular manipulation, treatment, and property detection.

  2014cites this paper
• Species D Human Adenovirus Type 9 Exhibits Better Virus-Spread Ability for Antitumor Efficacy among Alternative Serotypes

  2014cites this paper
• Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.

  2014cites this paper
• Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.

  2013cites this paper
• Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer

  2013cites this paper
• Targeting Intercellular Communication in Cancer Gene Therapy

  2013cites this paper
• Potentialisation de la virothérapie anti-tumorale basée sur des adénovirus oncolytiques dans le traitement des cancers côliques et rénaux

  2013cites this paper
• Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer

  2013cites this paper
• Targeting Adenoviral Entry to Enhance Oncolytic Antitumor Response

  2013cites this paper
• Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.

  2013cites this paper
• Experimental adenovirus gene therapy for cancer patients with advanced tumors : Translational medicine from basic research to the patient's bedside

  2013cites this paper
• Development and characterization of a recombinant vesicular stomatitis virus (rvsv) for the treatment of glioblastoma

  2013cites this paper
• Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer.

  2012cites this paper
• Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection

  2012cites this paper
• Basic and translational studies on species B adenoviruses

  2012cites this paper
• Coxsackie adenovirus receptor expression in carcinomas of the head and neck.

  2012cites this paper
• Novel Animal Models and Gene Therapy Applications for Glioblastoma Multiforme

  2012cites this paper
• HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice

  2012cites this paper
• Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.

  2012cites this paper
• Adenoviruses in Oncology

  2012influential citation
• Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy.

  2012cites this paper
• The roles of cell surface attachment molecules and coagulation Factor X in adenovirus 5-mediated gene transfer in pancreatic cancer cells

  2011cites this paper
• Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy.

  2011cites this paper
• Coxsackie and adenovirus receptor is a target and a mediator of estrogen action in breast cancer.

  2011cites this paper
• Replication-competent adenovirus 11p vector as a new oncolytic agent

  2011cites this paper
• Regulation and patterning of cell differentiation and pluripotency

  2011cites this paper
• Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data.

  2011cites this paper
• Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.

  2011cites this paper
• Expression of coxsackievirus and adenovirus receptor isoforms in developing mouse bladder uroepithelium.

  2011cites this paper
• EpCAM‐ and EGFR‐targeted selective gene therapy for biliary cancers using Z33‐fiber‐modified adenovirus

  2011cites this paper
• Increased expression of the coxsackie and adenovirus receptor downregulates αvβ3 and αvβ5 integrin expression and reduces cell adhesion and migration.

  2011cites this paper
• Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers

  2011cites this paper
• Expression of coxsackievirus and adenovirus receptor in human lung cancer: Possible clinical significance

  2010cites this paper
• Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors

  2010cites this paper
• Viral-based gene delivery and regulated gene expression for targeted cancer therapy

  2010cites this paper
• Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

  2010cites this paper
• Increasing the Efficacy of Oncolytic Adenovirus Vectors

  2010cites this paper
• Gene Transfer Vectors Targeted to Human Prostate Cancer: Do We Need Better Preclinical Testing Systems?

  2010cites this paper
• Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy.

  2010cites this paper
• Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells

  2010cites this paper
• Oncolytic (replication-competent) adenoviruses as anticancer agents

  2010cites this paper
• 29in Gene Therapy for Bladder Cancer

  2010cites this paper
• Targeting the p53-family in cancer and chemosensitivity: triple threat.

  2010cites this paper
• Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

  2010cites this paper
• Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer.

  2010cites this paper
• Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells.

  2010cites this paper
• Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions

  2010cites this paper
• Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.

  2009cites this paper
• Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.

  2009cites this paper